Project Grant HT94252410743
Award Date
7/15/24
Completion Date
7/14/27
Dollars Obligated
$617K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Great Britain, United Kingdom
Similar Awards
The University of Manchester received a $396,778 Project Grant award from the Defense Health Agency to model the risk of radiation-associated malignant progression in familial Neurofibromatosis type 2 (NF2) using machine learning approaches. The award was made under the Military Medical Research and Development program (CFDA 12.420), which supports biomedical research to improve military and public health care through innovative solutions for battlefield medicine and other areas. Over a...
This federal Project Grant award of $523,614.37, provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports advanced biomedical research into the genetic mechanisms underlying schwannomatosis and other rare conditions. The University of Manchester, a prominent research institution in the United Kingdom, will conduct this 3-year research initiative, focusing on elucidating the disease-specific genetic factors that distinguish...
The University of Manitoba was awarded a $249,823 Project Grant from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The award supports the university's research on the "Polygenicity of Brain and Physical Reserve in Multiple Sclerosis." The two-year project, running from September 1, 2025 to August 31, 2027, will investigate the genetic factors and brain/physical reserve mechanisms underlying multiple sclerosis. As a...
The Defense Health Agency awarded a $697,766 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to the Murdoch Children's Research Institute in Australia. The grant, awarded on July 15, 2024, will fund a 3-year research project titled "BRAIN CHARTS IN CHILDREN AND ADOLESCENTS WITH NEUROFIBROMATOSIS TYPE 1". The project aims to conduct biomedical research to better understand and characterize brain development in children and adolescents with...
This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) is providing $376,037 to the University of Birmingham in the United Kingdom. The funding supports a 3-year research project to assess retinal perfusion and blood flow as a surrogate measure for cerebral perfusion in individuals with severe traumatic brain injury. The University of Birmingham, an international non-profit research institution, will utilize advanced...
The University of Alabama at Birmingham will use a $148,500 Project Grant from the Defense Health Agency to support research titled "SMART-BASED REPAIR OF NF1 PRE-MRNA." The grant is part of the Military Medical Research and Development program (CFDA 12.420), which aims to transform military and public health care through innovative biomedical research solutions. Specifically, the university will investigate medical solutions for the battlefield by exploring RNA-based therapies to...
This Project Grant award, valued at $3,837,128.00, was provided by the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) federal grant program. The funding supports advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader public. The primary awardee, the University of New Mexico Health Sciences Center (UNM HSC), will conduct research to analyze neural inflammatory factors and...
The Michigan State University was awarded a $704,249 Project Grant from the Department of the Army Medical Command's Military Medical Research and Development program. The grant will fund research from July 2021 to June 2024 to uncover mechanisms underlying cognitive changes and sleep in neurofibromatosis type 1 (NF1). The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming military and public health care...
The Defense Health Agency awarded $603,000 to the Massachusetts General Hospital under the Military Medical Research and Development federal grant program (CFDA 12.420) to support the project "CLINICAL AND MRI PREDICTORS OF INTERNAL NEUROFIBROMA GROWTH IN NEUROFIBROMATOSIS TYPE 1" from September 30, 2021 through September 29, 2024. This project grant will fund research at Massachusetts General Hospital to investigate clinical and MRI predictors of internal neurofibroma growth in...
The University of Melbourne received a $1,109,929 federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to develop a neurotrophin therapy for clinical translation. The grant, awarded on September 1, 2024, will support research aimed at improving health outcomes for military service members, veterans, and the broader public by advancing innovative treatments for neurological disorders. The three-year project will...